Cargando…

Analytical Performance Characteristics of the Accelerate Pheno™ System for Pathogen Identification and Susceptibility Testing for Gram-negative Bacteremia and Candidemia

BACKGROUND: The Accelerate Pheno™ system is a novel fast diagnostic that significantly reduces the time to ID and AST for GNB and ID of Candida spp. bloodstream infections, with the potential to impact clinical outcomes. Prospective clinical trials are needed to evaluate the impact of this new syste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burnham, Jason, Wallace, Meghan, Fuller, Brian, Burnham, Carey-Ann D, Kollef, Marin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630707/ http://dx.doi.org/10.1093/ofid/ofx163.1570

Ejemplares similares

Clinical Impact of Expedited Pathogen Identification and Susceptibility Testing for Gram-negative Bacteremia and Candidemia Using the Accelerate Pheno™ System
por: Burnham, Jason, et al.
Publicado: (2017)

108. Impact of Accelerate Pheno System in the Management of Gram-Negative Rod Bacteremia
por: Ganapathiraju, Iaswarya, et al.
Publicado: (2020)

334. Clinical Outcomes with Implementation of Accelerate Pheno Blood Culture Detection System for Gram Negative Bacteremia
por: Lee, Shu Xian, et al.
Publicado: (2022)

Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of β-Lactam-Resistant Gram-Negative Bacteria
por: Gonzalez, Mark D., et al.
Publicado: (2017)

Systematic Evaluation of the Accelerate Pheno System for Susceptibility Testing of Gram-Negative Bacteria Isolated from Blood Cultures
por: Patel, Yera A., et al.
Publicado: (2021)

Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremia
por: Walsh, Thomas L., et al.
Publicado: (2021)

Identification and antimicrobial susceptibility testing of Gram-positive and Gram-negative bacteria from positive blood cultures using the Accelerate Pheno™ system
por: Ullberg, Måns, et al.
Publicado: (2019)

Pharmacist-Driven Implementation of Fast Identification and Antimicrobial Susceptibility Testing Improves Outcomes for Patients with Gram-Negative Bacteremia and Candidemia
por: Sheth, Sahil, et al.
Publicado: (2020)

Correction to: Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremia
por: Walsh, Thomas L., et al.
Publicado: (2021)

70. Impact of the Accelerate Pheno™ System on Clinical and Antimicrobial Outcomes among Inpatients with Gram-Negative Bacteremia at a 528-bed Community Teaching Hospital
por: DePasquale, William P, et al.
Publicado: (2021)

The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic
por: Reynolds, Daniel, et al.
Publicado: (2022)

Clinical impact of the accelerate PhenoTest® BC system on patients with gram-negative bacteremia and high risk of antimicrobial resistance: a prospective before-after implementation study
por: Brosh-Nissimov, Tal, et al.
Publicado: (2023)

Evaluation of Machine Learning and Rules-Based Approaches for Predicting Antimicrobial Resistance Profiles in Gram-negative Bacilli from Whole Genome Sequence Data
por: Pesesky, Mitchell W., et al.
Publicado: (2016)

1986. Rapid Identification and Antimicrobial Susceptibility Testing Utilizing the Accelerate Pheno™ System for Gram-Negative Bloodstream Infections and Its Potential Clinical Impact
por: Schneider, Jack, et al.
Publicado: (2018)

Impact of Accelerate Pheno System on Time to Antimicrobial Stewardship Intervention in Patients with Gram-Negative Blood Stream Infections
por: Elliott, Gerald, et al.
Publicado: (2017)

Clinical Impact of Rapid Identification (ID) and Phenotypic Antimicrobial Susceptibility Testing (AST) by Accelerate Pheno™ System (AXDX) for Gram-negative (GNB) Bloodstream Infections
por: Matic, Nancy, et al.
Publicado: (2017)

Evaluation of the Accelerate Pheno™ System for the Identification and Antimicrobial Susceptibilty Testing of Gram-negative Bacteria, Compared with Conventional Laboratory Testing
por: Roulston, Kerry, et al.
Publicado: (2017)

Bacteremia and resistant gram-negative pathogens among under-fives in Tanzania
por: Christopher, Alexandra, et al.
Publicado: (2013)

Visualizing genomic information across chromosomes with PhenoGram
por: Wolfe, Daniel, et al.
Publicado: (2013)

Evaluation of the impact of the Accelerate Pheno™ system on time to result for differing antimicrobial stewardship intervention models in patients with gram-negative bloodstream infections
por: Elliott, Gerald, et al.
Publicado: (2019)

Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia
por: Thomas-Rüddel, Daniel O., et al.
Publicado: (2018)

Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia
por: Abe, Ryuzo, et al.
Publicado: (2010)

Comparison of Risk Factors and Outcomes in Carbapenem-Resistant and Carbapenem-Susceptible Gram-Negative Bacteremia
por: Cetin, Sinan, et al.
Publicado: (2021)

Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials
por: Burnham, Jason P., et al.
Publicado: (2017)

Serum Cytokine Profile in Patients with Candidemia versus Bacteremia
por: Taj-Aldeen, Saad J., et al.
Publicado: (2021)

Prospective Evaluation of Accelerate Pheno™ System (AXDX) Version 1.1 for Reducing Turn-Around-Time (TAT) in Identification/Antimicrobial Susceptibility Testing (ID/AST) of Gram-Negative Bacilli (GNB) from Positive Blood Cultures (+BC) using AXDX PhenoTest™ BC Kits
por: Willey, Barbara M, et al.
Publicado: (2017)

292. Impact of the BACT/ALERT VIRTUO blood culture system in the management of Staphylococcus aureus bacteremia
por: Chavez, Miguel A, et al.
Publicado: (2020)

Catheter removal and outcomes of multidrug-resistant central-line-associated bloodstream infection
por: Burnham, Jason P., et al.
Publicado: (2018)

Clinical Impact of Revised Cefepime Breakpoint in Patients With Enterobacteriaceae Bacteremia
por: Foong, Kap Sum, et al.
Publicado: (2019)

Gram-negative versus Gram-positive bacteremia: what is more alarmin(g)?
por: Alexandraki, Irene, et al.
Publicado: (2010)

149. Short vs. Long Course of Antibiotics for Uncomplicated Gram-Negative Bacteremia
por: Go, James, et al.
Publicado: (2019)

Strongyloidiasis complicated by gram-negative bacteremia and liver abscesses
por: Ordaya, Eloy E., et al.
Publicado: (2022)

Risk for primary cephalosporin resistance in Gram-negative bacteremia
por: John, Princy, et al.
Publicado: (2023)

Candidemia on presentation to the hospital: development and validation of a risk score
por: Shorr, Andrew F, et al.
Publicado: (2009)

Procalcitonin levels in candidemia versus bacteremia: a systematic review
por: Cortegiani, Andrea, et al.
Publicado: (2019)

Retrospective Evaluation of Accelerate Pheno™ System (AXDX, Version 1.1) for Identification/Antimicrobial Susceptibility Testing (ID/AST) of Gram-Negative Bacilli (GNB) including Carbapenemase-Producing Organisms (CPO) from Seeded Blood Culture Bottles (SBCB) Tested using AXDX PhenoTest(TM) BC Kits
por: Willey, Barbara M, et al.
Publicado: (2017)

Procalcitonin Is a Marker of Gram-Negative Bacteremia in Patients With Sepsis
por: Guo, Shun Yuan, et al.
Publicado: (2015)

Analysis of Gram-negative rod bacteremia in the surgical and medical ICU
por: Adukauskiene, D, et al.
Publicado: (2015)

Antibiotic-Resistant Gram-Negative Bacteremia in Febrile Neutropenic Children
por: Lee, Jina
Publicado: (2016)

Impact of an Antimicrobial Stewardship Bundle for Uncomplicated Gram-Negative Bacteremia
por: Erickson, Reaghan M, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jv5j21qefltif0g56d5bbjogom